AGILENT TECHNOLOGIES, INC. (A) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2022-04-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2022-04-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2022-04-30..
Borrowing debt
Overview →Financial period ending 2022-04-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2022-04-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2022-04-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2022-04-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 2.73B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 10.46B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2022-04-30 | (m) | (m) | (m) | $2.73B | (m) | (m) | $10.46B | (m) |
| 2022-01-31 | (m) | (m) | (m) | $2.73B | (m) | (m) | $10.33B | (m) |
| 2021-10-31 | (m) | (m) | (m) | $2.73B | (m) | (m) | $10.71B | (m) |
| 2021-07-31 | (m) | (m) | (m) | $2.73B | (m) | (m) | $10.49B | (m) |
| 2021-04-30 | (m) | (m) | (m) | $2.73B | (m) | (m) | $10.40B | (m) |
| 2021-01-31 | (m) | (m) | (m) | $2.19B | (m) | (m) | $9.67B | (m) |
| 2020-10-31 | (m) | (m) | (m) | $2.28B | (m) | (m) | $9.63B | (m) |
| 2020-07-31 | (m) | (m) | (m) | $2.28B | (m) | (m) | $9.55B | (m) |
| 2020-04-30 | (m) | (m) | (m) | $1.79B | (m) | (m) | $9.46B | (m) |
| 2020-01-31 | (m) | (m) | (m) | $1.79B | (m) | (m) | $9.50B | (m) |
| 2019-10-31 | (m) | (m) | (m) | $1.79B | (m) | (m) | $9.45B | (m) |
| 2019-07-31 | (m) | (m) | (m) | $1.29B | (m) | (m) | $8.63B | (m) |
| 2019-04-30 | (m) | (m) | (m) | $1.80B | (m) | (m) | $9.02B | (m) |
| 2019-01-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.95B | (m) |
| 2018-11-01 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.56B | (m) |
| 2018-10-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.54B | (m) |
| 2018-07-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.35B | (m) |
| 2018-04-30 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.78B | (m) |
| 2018-01-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.70B | (m) |
| 2017-10-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.43B | (m) |
| 2017-07-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.26B | (m) |
| 2017-04-30 | (m) | (m) | (m) | $1.80B | (m) | (m) | $8.02B | (m) |
| 2017-01-31 | (m) | (m) | (m) | $1.80B | (m) | (m) | $7.87B | (m) |
| 2016-10-31 | (m) | (m) | (m) | $1.91B | (m) | (m) | $7.80B | (m) |
| 2016-07-31 | (m) | (m) | (m) | $1.65B | (m) | (m) | $7.73B | (m) |
| 2016-04-30 | (m) | (m) | (m) | $1.65B | (m) | (m) | $7.64B | (m) |
| 2016-01-31 | (m) | (m) | (m) | $1.65B | (m) | (m) | $7.30B | (m) |
| 2015-10-31 | (m) | (m) | (m) | $1.66B | (m) | (m) | $7.48B | (m) |
| 2015-07-31 | (m) | (m) | (m) | $1.66B | (m) | (m) | $7.25B | (m) |
| 2015-04-30 | (m) | (m) | (m) | $1.66B | (m) | (m) | $7.41B | (m) |
| 2015-01-31 | (m) | (m) | (m) | $1.66B | (m) | (m) | $7.52B | (m) |
| 2014-10-31 | (m) | (m) | (m) | $2.76B | (m) | (m) | $10.83B | (m) |
| 2014-07-31 | (m) | (m) | (m) | $2.18B | (m) | (m) | $10.38B | (m) |
| 2014-04-30 | (m) | (m) | (m) | $2.69B | (m) | (m) | $11.03B | (m) |
| 2014-01-31 | (m) | (m) | (m) | $2.69B | (m) | (m) | $10.64B | (m) |
| 2013-10-31 | (m) | (m) | (m) | $2.70B | (m) | (m) | $10.69B | (m) |
| 2013-07-31 | (m) | (m) | (m) | $2.70B | (m) | (m) | $10.28B | (m) |
| 2013-04-30 | (m) | (m) | (m) | $2.11B | (m) | (m) | $10.59B | (m) |
| 2013-01-31 | (m) | (m) | (m) | $2.11B | (m) | (m) | $10.65B | (m) |
| 2012-10-31 | (m) | (m) | (m) | $2.11B | (m) | (m) | $10.54B | (m) |
| 2012-07-31 | (m) | (m) | (m) | $1.71B | (m) | (m) | $9.76B | (m) |
| 2012-04-30 | (m) | (m) | (m) | $1.93B | (m) | (m) | $9.41B | (m) |
| 2012-01-31 | (m) | (m) | (m) | $1.93B | (m) | (m) | $9.10B | (m) |
| 2011-10-31 | (m) | (m) | (m) | $1.93B | (m) | (m) | $9.06B | (m) |
| 2011-07-31 | (m) | (m) | (m) | $2.17B | (m) | (m) | $8.75B | (m) |
| 2011-04-30 | (m) | (m) | (m) | $2.14B | (m) | (m) | $8.65B | (m) |
| 2011-01-31 | (m) | (m) | (m) | $2.14B | (m) | (m) | $8.04B | (m) |
| 2010-10-31 | (m) | (m) | (m) | $2.19B | (m) | (m) | $9.70B | (m) |
| 2010-07-31 | (m) | (m) | (m) | $2.18B | (m) | (m) | $9.10B | (m) |
| 2010-04-30 | (m) | (m) | (m) | $1.39B | (m) | (m) | $7.77B | (m) |
| 2010-01-31 | (m) | (m) | (m) | $1.41B | (m) | (m) | $7.57B | (m) |
| 2009-10-31 | (m) | (m) | (m) | $1.52B | (m) | (m) | $7.61B | (m) |
| 2009-07-31 | (m) | (m) | (m) | $1.51B | (m) | (m) | $6.57B | (m) |
| 2008-10-31 | (m) | (m) | (m) | $1.51B | (m) | (m) | $7.01B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |